CTLA4 and neoplasm: In this sense, it was discovered that the altered probiotic E. coli Nissle strain produced nanobodies that would target immunological checkpoints including cytotoxic t lymphocyte-associated protein-4 and programmed death-ligand 1 intratumorally, as well as a possible tumor-reducing capacity [21].